Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Curr Pediatr Rev ; 20(3): 265-270, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-37702164

RESUMEN

The introduction of biological drugs for the treatment of severe allergic asthma in children, almost twenty years ago, had a substantial impact on both the pathology's clinical course and the quality of life of the patients who receive treatment. Over the years, several molecules have been developed that inhibit molecular targets involved in the pathogenesis of the asthmatic disease. Biological drugs demonstrate a significant improvement in several key clinical parameters in patients with severe asthma. In this review, we provide a concise summary of the evidence on biological therapy for children and adolescents with severe asthma.


Asunto(s)
Antiasmáticos , Asma , Productos Biológicos , Adolescente , Niño , Humanos , Omalizumab/uso terapéutico , Antiasmáticos/uso terapéutico , Antiasmáticos/efectos adversos , Calidad de Vida , Productos Biológicos/uso terapéutico , Asma/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA